Skip to main content
Watch Insiders
RXRX filings

Corporate insider profile

Namandje Bumpus Filing Activity

Latest reported as Corporate insider of RECURSION PHARMACEUTICALS, INC. (RXRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$28,128.78
Latest transaction
Jun 18, 2026

Affiliated corporations

Reported company relationships

RXRXLatest reported

RECURSION PHARMACEUTICALS, INC.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 18, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale3,963$3.18$12,602
Jun 3, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale4,386$3.54$15,526